These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7892031)

  • 1. Computerized nuclear morphometry and survival in renal cell carcinoma: comparison with other prognostic indicators.
    Delahunt B; Becker RL; Bethwaite PB; Ribas JL
    Pathology; 1994 Oct; 26(4):353-8. PubMed ID: 7892031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma.
    Sika-Paotonu D; Bethwaite PB; McCredie MR; William Jordan T; Delahunt B
    Am J Surg Pathol; 2006 Sep; 30(9):1091-6. PubMed ID: 16931953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of nuclear morphometry in renal cell carcinoma.
    Ozer E; Yörükoğlu K; Sagol O; Mungan U; Demirel D; Tüzel E; Kirkali Z
    BJU Int; 2002 Jul; 90(1):20-5. PubMed ID: 12081763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of morphometric nuclear image analysis using the Feulgen reaction in renal cell carcinoma.
    Lee JS; Jung JJ; Lee MC; Park CS; Juhng SW; Oh BR; Moon JD
    Anal Quant Cytol Histol; 2000 Feb; 22(1):31-6. PubMed ID: 10696458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma.
    Eskelinen M; Lipponen P; Aitto-Oja L; Hall O; Syrjänen K
    Int J Cancer; 1993 Oct; 55(4):547-54. PubMed ID: 8406980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear quantitative grading by discriminant analysis of renal cell carcinoma samples. A patient survival evaluation.
    Artacho-Pérula E; Roldán-Villalobos R; Martínez-Cuevas JF; López-Rubio F
    J Pathol; 1994 Jun; 173(2):105-14. PubMed ID: 8089804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneity.
    van der Poel HG; Mulders PF; Oosterhof GO; Schaafsma HE; Hendriks JC; Schalken JA; Debruyne FM
    Cancer; 1993 Nov; 72(9):2667-74. PubMed ID: 8402488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic prognostic indicators for renal cell carcinoma.
    Delahunt B
    Semin Diagn Pathol; 1998 Feb; 15(1):68-76. PubMed ID: 9503507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective nuclear morphometry as a prognostic factor of survival in renal cell carcinoma.
    Monge JM; Val-Bernal JF; Buelta L; García-Castrillo L; Asensio L
    Histol Histopathol; 1999 Jan; 14(1):119-23. PubMed ID: 9987656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between histological grade and nuclear morphometry for predicting the clinical outcome of localized renal cell carcinoma.
    Nativ O; Sabo E; Bejar J; Halachmi S; Moskovitz B; Miselevich I
    Br J Urol; 1996 Jul; 78(1):33-8. PubMed ID: 8795397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
    Delahunt B; Bethwaite PB; Thornton A; Ribas JL
    Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear morphometry of renal cell carcinomas.
    Barth PJ; Siebel A; Gerharz E; Köhler HH
    Gen Diagn Pathol; 1995 May; 141(1):29-33. PubMed ID: 8542504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleolar organizer regions and prognosis in renal cell carcinoma.
    Delahunt B; Ribas JL; Nacey JN; Bethwaite PB
    J Pathol; 1991 Jan; 163(1):31-7. PubMed ID: 2002422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW
    Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
    Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the prognostic value of nuclear grade and silver-binding nucleolar organizer region in renal cell carcinomas.
    Yang AH; Wang TY; Liu HC
    J Pathol; 1992 Feb; 166(2):157-61. PubMed ID: 1560316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear morphometry in male breast carcinoma: association with cell proliferative activity, oncogene expression, DNA content and prognosis.
    Chiusa L; Margaria E; Pich A
    Int J Cancer; 2000 Nov; 89(6):494-9. PubMed ID: 11102893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural morphometry of nucleoli: potential usefulness for objective grading of clear cell renal cell carcinoma.
    Lloreta-Trull J; Bielsa-Galí O; Domínguez-Solà D; Arumí-Uría M; Pavesi M; Gelabert A; Serrano-Figueras S
    Ultrastruct Pathol; 2001; 25(2):105-10. PubMed ID: 11407523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
    Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
    Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
    Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.